Latest N-terminal prohormone of brain natriuretic peptide Stories
LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries.
A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction.
- Statistically significant and durable reductions in troponin and NT-proBNP SAN DIEGO, Feb.
Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, diastolic dysfunction, and heart failure as well as emergency cardiovascular hospitalizations.
- A trick or prank.